Edition:
United States

Michael Erman

Jeff Mason is a White House Correspondent for Reuters and the 2016-2017 president of the White House Correspondents’ Association. He was the lead Reuters correspondent for President Barack Obama's 2012 campaign and interviewed the president at the White House in 2015. Jeff has been based in Washington since 2008, when he covered the historic race between Obama, Hillary Clinton and John McCain. Jeff started his career in Frankfurt, Germany, where he covered the airline industry before moving to Brussels, Belgium, where he covered the European Union. He is a Colorado native, proud graduate of Northwestern University and former Fulbright scholar.

Twitter handle: @jeffmason1

Sep 07 2017

Lilly to lay off 8 percent of employees in bid to cut costs

Eli Lilly and Co said on Thursday it would lay off about 8 percent of its employees as the drugmaker, which has suffered setbacks over the past year in the development of two potential blockbuster drugs, works to cut costs.

Aug 31 2017

Tenet to replace CEO, board directors under activist pressure

NEW YORK Tenet Healthcare Corp said on Thursday it would replace longtime Chief Executive Trevor Fetter and members of its board, as pressure builds from its largest shareholder to shake up the hospital company's management.

Aug 29 2017

Abbott releases new round of cyber updates for St. Jude pacemakers

NEW YORK Abbott Laboratories said on Tuesday it would issue updates to reduce the risk of its St. Jude heart implants being hacked and to warn patients that the devices' batteries may run down earlier than expected.

Aug 28 2017

Gilead to buy Kite for promising cancer therapies in $12 billion deal

Gilead Sciences Inc agreed to buy Kite Pharma Inc in a nearly $12 billion deal on Monday, as it looks to replace flagging sales from hepatitis C drugs with an emerging and expensive class of cancer immunotherapies that are expected to generate billions of dollars in revenue.

Aug 18 2017

Glenview directors leave Tenet board, cite irreconcilable differences

NEW YORK Glenview Capital Management, Tenet Healthcare Corp's largest shareholder, pulled its two representatives off the hospital company's board, citing "irreconcilable differences" over strategy.

Aug 17 2017

U.S. House Democrats launch probe into MS drug pricing

NEW YORK U.S. House Democrats said on Thursday they were launching an investigation into why prices for Multiple Sclerosis (MS) treatments have nearly quintupled since 2004, and they sent letters requesting information from seven drugmakers.

Aug 17 2017

Trump disbands business councils after CEOs quit in protest

WASHINGTON/NEW YORK President Donald Trump disbanded two high-profile business advisory councils on Wednesday after several chief executives quit in protest over his remarks blaming weekend violence in Virginia on anti-racism activists as well as white nationalists. | Video

Aug 16 2017

UnitedHealth names Wichmann CEO, Hemsley executive chairman

NEW YORK UnitedHealth Group Inc said on Wednesday president David Wichmann will become the company's chief executive, succeeding Stephen Hemsley, who is moving to the newly created role of executive chairman after more than a decade at the helm of the largest U.S. health insurer.

Aug 15 2017

Three CEOs resign from Trump council over Charlottesville

The chief executives of Intel Corp, Merck & Co Inc and Under Armour Inc resigned from U.S. President Donald Trump's American Manufacturing Council on Monday, following Trump's initially tepid response to weekend violence at a rally of white supremacists in Charlottesville, Virginia. | Video

Aug 09 2017

Mylan cuts forecasts on delays in new drugs, weak prices

Mylan NV said on Wednesday that delays in launching key new drugs and eroding prices for generics in the United States will hurt its profitability this year and in 2018. | Video

Markets

  • U.S.
  • Europe
  • Asia
  • Sectors

Sector Summary